Nasdaq

NuVasive Simplify Cervical Disc Data Published In International Journal Of Spine Surgery

SAN DIEGO, Sept. 9, 2021 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally ...
Yahoo Finance

Five-Year Study Outcomes of the NuVasive Simplify Cervical Disc were Presented at the North American Spine Society 38th Annual Meeting

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
Nasdaq

NuVasive Simplify Cervical Disc Two-level Data Published in Journal of Neurosurgery: Spine

Peer-reviewed results from the two-level multi-center FDA Investigational Device Exemption study reiterate disc's superiority to ACDF The peer-reviewed publication reiterates that the Simplify Disc ...
Yahoo Finance

FDA Approves NuVasive’s Simplify Disc For Two-Level Cervical Total Disc Replacement

NuVasive announced that the US Food and Drug Administration (FDA) has approved the NuVasive Simplify Cervical Artificial Disc (Simplify Disc) for two-level cervical total disc replacement (cTDR).
Business Insider

Clinical Study Demonstrates NuVasive Cohere® Porous PEEK™ Spinal Interbody Promotes Improved Early Outcomes Over Structural Allograft And Smooth PEEK

SAN DIEGO, April 22, 2019 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally ...
Stockhouse

NuVasive's Simplify Disc Receives FDA Approval for Two-Level Cervical Total Disc Replacement

SAN DIEGO , April 6, 2021 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally ...
Mena FN

NuVasive Simplify Cervical Disc Two-level Data Published in Journal of Neurosurgery: Spine'

Peer-reviewed results from the two-level multi-center FDA Investigational Device Exemption study reiterate disc's superiority to ACDF SAN DIEGO, April 21, 2022 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: ...